Singer Capital Markets was delighted to host our latest Singer Growth Economy themed event “The Future of Medicine: Efficiency through the Cycle from Drug Discovery to Consumer.” The event featured presentations from 6 leading healthcare companies who explored the remarkable advancements in the medical industry, driven primarily by advances in the use of AI across the entire value chain of drug discovery, development and commercialisation.

In addition to the company presentations, the event also featured expert insights from Dr. Ivan Griffin, who is the Co-Founder & Chief Operating Officer of BenevolentAI.

For more information on this event, and/or to request the event recording, please contact sge@singercm.com

In these uncertain times it has never been more important for us to nurture and support growth companies. Our economy must recoup the considerable costs of recent crises and our firm belief is that this can only be achieved by stimulating productivity in our great nation’s innovators, disrupters and challengers.

The Singer Growth Economy highlights opportunities across four overarching themes: Health & Wellbeing of the Population, Transition to a Sustainable Economy, Innovation & Emerging Technologies and Geopolitics & Demographics. Within these themes we have identified what we believe to be the most powerful growth drivers shaping the future of our economy, playing out not over months, or even years, but over decades.